Ask AI
ProCE Banner Activity

Wherever the Bloodstream Goes, the Staph aureus Goes, Too

Clinical Thought

Are the SNAP and DOTS trials the best advances in management of Staph aureus spectrum we’ve had in some time?

Released: December 31, 2025

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Innoviva Specialty Therapeutics, Inc.

Innoviva Specialty Therapeutics, Inc

Target Audience

This activity is intended for clinical specialists including physicians, clinical pharmacists, and other healthcare professionals involved in the care of patients with S. aureus BSIs.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Individualize antibiotic strategies for patients with complex S. aureus BSIs 

  • Modify antibiotic regimens for clinical infections involving persistent S. aureus bacteremia

  • Appraise the role of β-lactams in the treatment of complicated MRSA bloodstream infections

Disclosure

Primary Author

Paul E. Sax, MD: consultant/advisor/speaker: Gilead, Merck, Shionogi, ViiV,